Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Alcon Inc. Investors

< Previous 1 2 3 Next >
News headline image
Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon to Present at 2023 Annual J.P. Morgan Healthcare Conference
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Prices US$1.3 Billion Senior Notes Offering
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
From Alcon Inc. Investors
Via Business Wire
Tickers AERI ALC
News headline image
Alcon Reports Third Quarter 2022 Results
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon to Celebrate 75 Years of Brilliance and Showcase Contact Lens Innovations at #Academy22
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
From Alcon Inc. Investors
Via Business Wire
Tickers AERI ALC
News headline image
Alcon Reports Second Quarter 2022 Results
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Prices EUR 500.0 Million Senior Notes Offering
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Reports First Quarter 2022 Results
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Announces Results of 2022 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon to Deliver Robust Scientific Program at ASCRS 2022
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Publishes Agenda for 2022 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Reports Fourth Quarter and Full Year 2021 Results
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Reports Third Quarter 2021 Results
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Reports Second Quarter 2021 Results
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Announces Executive Committee Changes
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Reports First Quarter 2021 Results
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
News headline image
Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S.
From Alcon Inc. Investors
Via Business Wire
Tickers ALC
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.